Anika Therapeutics (ANIK) EBT Growth (1y) (2011 - 2026)
Anika Therapeutics (ANIK) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Anika Therapeutics | 285.93 Mn | 247.52 Mn | 21.24 Mn | 185.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 185.22% |
| Mar 31, 2026 | -24.61% |
| Dec 31, 2025 | 86.20% |
| Sep 30, 2025 | -788.00% |
| Jun 30, 2025 | -226.42% |
| Mar 31, 2025 | -102.25% |
| Dec 31, 2024 | -105.04% |
| Sep 30, 2024 | 104.62% |
| Jun 30, 2024 | 60.42% |
| Mar 31, 2024 | 84.08% |
| Dec 31, 2023 | 51.56% |
| Sep 30, 2023 | -31.28% |
| Jun 30, 2023 | 6.54% |
| Mar 31, 2023 | -224.00% |
| Dec 31, 2022 | 351.15% |
| Sep 30, 2022 | -528.27% |
| Jun 30, 2022 | -135.98% |
| Mar 31, 2022 | -405.19% |
| Dec 31, 2021 | 63.38% |
| Sep 30, 2021 | 115.35% |